Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis-Reference-Cited by-同舟云学术

Efficacy and Safety of Difelikefalin in Japanese Patients With Moderate to Severe Pruritus Receiving Hemodialysis

Published:2022-05-05 Issue:5 Volume:5 Page:e2210339
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Narita Ichiei¹,Tsubakihara Yoshiharu²,Uchiyama Takuma³,Okamura Shota³,Oya Nobuyo⁴,Takahashi Naoki⁴,Gejyo Fumitake⁵,Yamamoto Akikazu⁶,Ichikawa Akiko⁶,Ohishi Akira⁶,Ishimura Atsunori⁶,Fuse Haruki⁶,Yoshida Hideaki⁶,Yoshinaga Hidetoshi⁶,Okada Hirokazu⁶,Sanematsu Hiromi⁶,Mizuno Hiroshi⁶,Seshita Hiroshi⁶,Kinuno Hiroyuki⁶,Shimizu Hiroyuki⁶,Degawa Hisakazu⁶,Shimada Hisaki⁶,Sasagawa Isoji⁶,Kim Jong II⁶,Takemura Katsumi⁶,Matsuoka Kazue⁶,Yoshimoto Keiichi⁶,Miki Keiya⁶,Yaginuma Kenji⁶,Kiyoki Kitagawa⁶,Shimoji Kunihiro⁶,Takayama Kuniko⁶,Oka Machiko⁶,Tsuchida Makoto⁶,Oki Mamoru⁶,Ogura Manabu⁶,Kakihara Masahiro⁶,Yanase Masahiro⁶,Otsuka Masakazu⁶,Hashimoto Masami⁶,Matsukawa Masanori⁶,Mori Masaru⁶,Fukue Masataka⁶,Sato Masatsugu⁶,Yoshihara Mayumi⁶,Fukunaga Megumu⁶,Nishihira Morikuni⁶,Ikeda Naofumi⁶,Ueda Naokazu⁶,Odaguchi Naoyuki⁶,Aizawa Nobuyuki⁶,Ikebe Norisato⁶,Itami Noritomo⁶,Degawa Noriyuki⁶,Okada Noriyuki⁶,Ishii Sakae⁶,Miyazato Sakae⁶,Funakoshi Satoshi⁶,Fukazawa Sawako⁶,Ando Shigeki⁶,Toma Shigeki⁶,Hayashi Shinji⁶,Kageyama Shinji⁶,Yano Shintaro⁶,Fujisawa Shoji⁶,Yanagida Taihei⁶,Yajima Takahiro⁶,Udagawa Takashi⁶,Toyoyama Takayuki⁶,Nakanishi Takeshi⁶,Misaki Taro⁶,Makiishi Tetsuya⁶,Endo Toko⁶,Suzuki Tomio⁶,Hasegawa Toru⁶,Kawai Toru⁶,Shiratori Toru⁶,Nishio Toshiki⁶,Shibata Toshiro⁶,Ishida Toshiya⁶,Takahashi Toshiyuki⁶,Saiki Toyonori⁶,Shikano Tsutomu⁶,Takahashi Yasufumi⁶,Onodera Yasuhiro⁶,Ushiogi Yasuyuki⁶,Akamatsu Yorihiro⁶,Otsubo Yoshihiko⁶,Shoji Yoshimi⁶,Saka Yosuke⁶,

Affiliation:

1. Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan

2. Graduate School of Medical Safety Management, Jikei University of Health Care Sciences, Osaka, Japan

3. Kissei Pharmaceutical Co Ltd, Tokyo, Japan

4. Maruishi Pharmaceutical Co Ltd, Osaka, Japan

5. Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan

6. for the MR13A9-4 Trial Investigators

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2791876/narita_2022_oi_220311_1651162484.79073.pdf

Reference26 articles.

1. Uremic pruritus.;Mettang;Kidney Int,2015

2. Pruritus in kidney disease.;Combs;Semin Nephrol,2015

3. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients.;Narita;Kidney Int,2006

4. Pruritus in hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Patterns Study (JDOPPS).;Kimata;Hemodial Int,2014

5. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).;Pisoni;Nephrol Dial Transplant,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in GPCR-targeted drug development in dermatology;Trends in Pharmacological Sciences;2024-08

2. The efficacy and safety of difelikefalin for pruritus in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials;Renal Failure;2024-08

3. Chronic Pruritus;JAMA;2024-06-25

4. Blood Purification for the Treatment of Chronic Kidney Disease-associated Pruritus;Integrative Medicine in Nephrology and Andrology;2024-04-23

5. Efficacy and safety of different systemic drugs in the treatment of uremic pruritus among hemodialysis patients: a network meta-analysis based on randomized clinical trials;Frontiers in Medicine;2024-04-05